 |
|
|
|
|
|
|
| [Close this page] | ||||||
|
|
Clanotech is in the process of discovering and developing small molecules that inhibit VEGFRs and integrin for oral treatment of cancer and wet macula degeneration (AMD). Contact: Patrizia Caldirola CEO Phone: +46 (0) 70 37 47 179 Email:
|
|||||
Clanotech
AB 